CEA-ANTIKÖRPER

European patent · EP2681244 · In force

Register entry

Publication number
EP2681244
Application number
EP12707732
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Feb 29, 2012
Published
Jan 8, 2014
Granted
Nov 29, 2017
Protection ends at the latest
Feb 28, 2032
Next annual fee due
Feb 28, 2027
IPC classes
C07K 16/30 (2006.01)
Priority
EP 11156665 02.03.2011
PCT application
PCT/EP2012/053390 29.02.2012
PCT publication
WO2012/117002 07.09.2012
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Mar 1, 2026

    Change

    Published in Swissreg on 01.03.2026

  2. Mar 1, 2025

    Change

    Published in Swissreg on 01.03.2025

  3. Mar 1, 2024

    Change

    Published in Swissreg on 01.03.2024

  4. Mar 6, 2023

    Change

    Published in Swissreg on 06.03.2023

  5. Oct 19, 2021

    Address changed

    Owner
    Roche Glycart AG, Wagistrasse 18, 8952 Schlieren → Roche Glycart AG, Wagistrasse 10, 8952 Schlieren

    Published in Swissreg on 19.10.2021

  6. Nov 29, 2017

    Granted

    Published in Swissreg on 29.11.2017

Parties

Holder

Roche Glycart AG

Wagistrasse 10, 8952 Schlieren

Inventor

HOFER, Thomas U.

CH-8052 Zuerich

HOSSE, Ralf

CH-6330 Cham

MOESSNER, Ekkehard

CH-8280 Kreuzlingen

UMANA, Pablo

CH-8832 Wollerau

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.